Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part III - Prevention of Diseases › Chapter 27 - COMMUNICABLE AND NONCOMMUNICABLE DISEASES › Subchapter B - REPORTING OF DISEASES, INFECTIONS AND CONDITIONS › GENERAL › Section 27.22 - Reporting of cases by clinical laboratories

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A person who is in charge of a clinical
					 laboratory in which a laboratory test of a specimen derived from a human body
					 yields microscopical, cultural, immunological, serological, chemical,
					 virologic, nucleic acid (DNA or RNA) or other evidence significant from a
					 public health standpoint of the presence of a disease, infection or condition
					 listed in subsection (b) shall promptly report the findings, no later than the
					 next work day after the close of business on the day on which the test was
					 completed, except as otherwise noted in this chapter.
(b) The diseases, infections and conditions
					 to be reported include the following:
Amebiasis.
Anthrax.
An unusual cluster of isolates.
Arboviruses.
Botulism-all forms.
Brucellosis.
CD4 T-lymphocyte counts and percentages.
Campylobacteriosis.
Cancer.
Chancroid.
Chickenpox (varicella).
Chlamydia trachomatis infections.
Cholera.
Congential adrenal hyperplasia (CAH) in children under 5
						years of age.
Creutzfeldt-Jakob disease.
Cryptosporidiosis.
Diphtheria infections.
Enterohemorrhagic E. coli 0157 infections, or infections
						caused by other subtypes producing shiga-like toxin.
Galactosemia in children under 5 years of age.
Giardiasis.
Gonococcal infections.
Granuloma inguinale.
HIV (Human Immunodeficiency Virus).
HIV viral load results, including detectable and
						undetectable viral load results, and HIV genotype test results.
Haemophilus influenzae infections-invasive from sterile
						sites.
Hantavirus.
Hepatitis, viral, acute and chronic cases.
Histoplasmosis.
Influenza.
Lead poisoning.
Legionellosis.
Leprosy (Hansen's disease).
Leptospirosis.
Listeriosis.
Lyme disease.
Lymphogranuloma venereum.
Malaria.
Maple syrup urine disease (MSUD) in children under 5
						years of age.
Measles (rubeola).
Meningococcal infections-invasive from sterile
						sites.
Mumps.
Pertussis.
Phenylketonuria (PKU) in children under 5 years of
						age.
Primary congenital hypothyroidism in children under 5
						years of age.
Plague.
Poliomyelitis.
Psittacosis (ornithosis).
Rabies.
Respiratory syncytial virus.
Rickettsial infections.
Rubella.
Salmonella.
Shigella.
Sickle cell disease in children under 5 years of
						age.
Staphylococcus aureus Vancomycin-resistant (or
						intermediate) invasive disease.
Streptococcus pneumoniae, drug-resistant invasive
						disease.
Syphilis.
Tetanus.
Toxoplasmosis.
Trichinosis.
Tuberculosis, confirmation of positive smears or
						cultures, including results of drug susceptibility testing.
Tularemia.
Typhoid.
(c) The report shall include the following,
					 except as provided in subsection (d):
(1) The
					 name, age, address and telephone number of the person from whom the specimen
					 was obtained.
(2) The date the
					 specimen was collected.
(3) The
					 source of the specimen (such as, serum, stool, CSF, wound).
(4) The name of the test or examination
					 performed and the date it was performed.
(5) The results of the test.
(6) The range of normal values for the
					 specific test performed.
(7) The
					 name, address and telephone number of the physician for whom the examination or
					 test was performed.
(8) Other
					 information requested in case reports or formats specified by the
					 Department.